Thu, January 15, 2009
Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008

ImmunoGen, Inc. Announces Webcast of Presentation at the 27th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. 7th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on , Last Modified on 2009-01-08 04:04:21 by Market Wire   Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference at 9:30 am PST on January 15, 2009. The Conference is being held at the Westin St. Francis hotel in San Francisco, CA. ImmunoGen's presentation will be webcast live and can be accessed through the "Investor Information" section of our website, [ www.immunogen.com ]. An archive of the webcast will be available at the same location until January 22, 2009.

About ImmunoGen, Inc.

ImmunoGen, Inc. develops targeted anticancer therapeutics using its expertise in cancer biology, monoclonal antibodies and the creation and attachment of potent cell-killing agents. The Company's Tumor-Activated Prodrug (TAP) technology uses antibodies to deliver one of ImmunoGen's proprietary cell-killing agents specifically to cancer targets. In addition to the Company's proprietary clinical pipeline, ImmunoGen collaborators Genentech, sanofi-aventis, Biogen Idec, and Biotest also are testing TAP compounds in the clinic, and the naked antibody AVE1642 is in clinical trials through the Company's collaboration with sanofi-aventis. Other ImmunoGen collaborative partners include Bayer HealthCare and Amgen.


Publication Contributing Sources

Similar Health and Fitness Publications